Pekka Taimen

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)

Cancers

Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

European Radiology

Beheshti Mohsen, Taimen Pekka, Kemppainen Jukka, Jambor Ivan, Mueller Andre, Loidl Wolfgang, Kähkönen Esa, Käkelä Meeri, Berndt Mathias, Stephens Andrew W., Minn Heikki, Langsteger Werner

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

Frontiers in Oncology

Anttinen Mikael, Sequeiros Roberto Blanco, Boström Peter J, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

BMJ Open

Ettala Otto, Jambor Ivan, Perez Ileana Montoya, Seppänen Marjo, Kaipia Antti, Seikkula Heikki, Syvänen Kari T, Taimen Pekka, Verho Janne, Steiner Aida, Saunavaara Jani, Saukko Ekaterina, Löyttyniemi Eliisa, Sjoberg Daniel D, Vickers Andrew, Aronen Hannu, Boström Peter

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

Frontiers in cell and developmental biology

West Gun, Turunen Minttu, Aalto Anna, Virtanen Laura, Li Song-Ping, Heliö Tiina, Meinander Annika, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Human Molecular Genetics

Wahlström Gudrun, Heron Samuel, Knuuttila Matias, Kaikkonen Elina, Tulonen Nea, Metsälä Olli, Lof Christoffer, Ettala Otto, Boström Peter J., Taimen Pekka, Poutanen Matti, Schleutker Johanna

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2022)

European Urology

Peters M., Eldred-Evans D., Kurver P., Falagario U.G., Connor M.J., Shah T.T., Verhoeff J.J.C., Taimen P., Aronen H.J., Knaapila J., Montoya Perez I., Ettala O., Stabile A., Gandaglia G., Fossati N., Martini A., Cucchiara V., Briganti A., Lantz A., Picker W., Haug E.S., Nordström T., Tanaka M.B., Reddy D., Bass E., van Rossum P.S.N., Wong K., Tam H., Winkler M., Gordon S., Qazi H., Boström P.J., Jambor I., Ahmed H.U.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations (2022)

Nature Communications

Le Dour Caroline, Chatzifrangkeskou Maria, Macquart Coline, Magiera Maria M., Peccate Cécile, Jouve Charlène, Virtanen Laura, Heliö Tiina, Aalto-Setälä Katriina, Crasto Silvia, Cadot Bruno, Cardoso Déborah, Mougenot Nathalie, Adesse Daniel, Di Pasquale Elisa, Hulot Jean Sébastien, Taimen Pekka, Janke Carsten, Muchir Antoine

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator (2022)

European Urology Open Science

Parekh Sneha, Ratnani Parita, Falagario Ugo, Lundon Dara, Kewlani Deepshikha, Nasri Jordan, Dovey Zach, Stroumbakis Dimitrios, Ranti Daniel, Grauer Ralph, Sobotka Stanislaw, Pedraza Adriana, Wagaskar Vinayak, Mistry Lajja, Jambor Ivan, Lantz Anna, Ettala Otto, Stabile Armando, Taimen Pekka, Aronen Hannu J, Knaapila Juha, Perez Ileana Montoya, Gandaglia Giorgio, Martini Alberto, Picker Wolfgang, Haug Erik, Cormio Luigi, Nordström Tobias, Briganti Alberto, Boström Peter J, Carrieri Giuseppe, Haines Kenneth, Gorin Michael A, Wiklund Peter, Menon Mani, Tewari Ash

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, 89Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis (2022)

Journal of Nuclear Medicine

Moisio Olli, Virta Jenni, Yatkin Emrah, Liljenbäck Heidi, Palani Senthil, Viitanen Riikka, Miner Maxwell WG, Oikonen Vesa, Tolvanen Tuula, Vugts Danielle J, Taimen Pekka, Li Xiang-Guo, Hollmén Maija, Jalkanen Sirpa, Roivainen Anne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations (2022)

Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, 89Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis (2022)